Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore

Natasha Fay Anthony, Yen-Lin Chee, Pak Ling Lui, Esther Chan, Michelle Poon, Lip Kun Tan, Jameelah Binte Sekh Mohamed, Liang Piu Koh, Melissa G OOI, Wee-Joo Chng, Wei-Ying Jen

Blood (2024) 144 (Supplement 1): 7899.

https://doi.org/10.1182/blood-2024-198845

Published: 2024

Journal Articles

Evaluating the Comprehensive Geriatric Assessment Model As an Assessment Tool to Predict Chemotoxicity in Elderly Patients with Lymphoma

Xinjie Jonathan Tang, Joanne Shu Xian Lee, Esther Hian Li Chan, Sanjay De Mel, Yen-Lin Chee, Wee-Joo Chng, Michelle Limei Poon, Shi Hui Clarice Choong, Melissa Gaik-Ming Ooi

Blood (2024) 144 (Supplement 1): 388.

https://doi.org/10.1182/blood-2024-198867

Published: 2024

Journal Articles

Outcomes of Elderly Patients with DLBCL and Utility of Geriatric Assessment Tools to Predict Chemotoxicity

Xinjie Jonathan Tang, Joanne Shu Xian Lee, Esther Hian Li Chan, Sanjay De Mel, Yen-Lin Chee, Wee-Joo Chng, Nicole-Ann Lim, Jason Yongsheng Chan, Soon Thye Lim, Shi Hui Clarice Choong, Melissa Gaik-Ming Ooi, Michelle Limei Poon

Blood (2024) 144 (Supplement 1): 3660.

https://doi.org/10.1182/blood-2024-208906

Published: 2024

Journal Articles

Development of a Novel Artificial Intelligence Tool to Measure Psoas Volumes in Patients with Diffuse Large B Cell Lymphoma

Edwin Wei Sheng Thong, Andrew Makmur, Yen-Lin Chee, James Hallihan, Lenith Tai Jit Cheng, Nesaretnam Barr Kumarakulasinghe, Anand Devaprasath Jeyasekharan, Joanne Shu Xian Lee, Sanjay De Mel, Esther Hian Li Chan, Michelle Poon, Wee-Joo Chng, Jayalakshmi ., Melati Dewi Ali, Wei-Ying Jen, Desmond Shi Wei Lim

Blood (2023) 142 (Supplement 1): 3652.

https://doi.org/10.1182/blood-2023-178239

Published: 2023

Journal Articles

A Non-Coding Variant in LOC105371512 Confers Susceptibility to Bleomycin-Induced Lung Injury

Blood (2022) 140 (Supplement 1): 4542–4544.

https://doi.org/10.1182/blood-2022-169416

Published: 2022

Journal Articles

An Ex-Vivo Combination Drug Sensitivity Platform for Predicting Sensitivity to FLT3 Inhibitor-Based Combination in Acute Myeloid Leukemia

Noor Rashidha Binte Meera Sahib, Jen Wei Ying, Melissa Ooi, Yen Lin Chee, Masturah Rashid, Jayalakshmi Jayalakshmi, Edward KH Chow

Blood (2022) 140 (Supplement 1): 7840–7841.

https://doi.org/10.1182/blood-2022-171110

Published: 2022

Journal Articles

Cepp in Previously Untreated Patients with Mature T Cell Lymphomas

Hian Li Esther Chan, Joanne Lee, Sanjay De Mel, Anand Devaprasath D. Jeyasekharan, Yen Lin Chee, Lay Poh Khoo, Yong Sheng Jason Chan, Soon Thye Lim, Michelle Poon, Nagavalli Somasundaram

Blood (2021) 138 (Supplement 1): 1371.

https://doi.org/10.1182/blood-2021-152633

Published: 2021

Journal Articles

Evaluating Front Line Treatment Regimens for Waldenstrom Macroglobulinaemia: A Systematic Review and Meta-Analysis

Wee Lee William Chan, Vanessa CL Chong, Ian JY Wee, Anand Jeyasekharan, Michelle Poon, Hian Li Esther Chan, Joanne Lee, Yen Lin Chee, Wee-Joo Chng, Miny Samuel, Sanjay de Mel

Blood (2021) 138 (Supplement 1): 1358.

https://doi.org/10.1182/blood-2021-150678

Published: 2021

Journal Articles

Clinical Application of an Ex-Vivo Platform to Guide the Choice of Drug Combinations in Relapsed/Refractory Lymphoma; A Prospective Study

Blood (2021) 138 (Supplement 1): 720.

https://doi.org/10.1182/blood-2021-149331

Published: 2021

Journal Articles

Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project

Ednajoy Ngo, Cheng Ean Chee, MBBS, ABIM (MDOnc), ABIM (Heme), FCAP, Melinda Khoo, BSc (Hons), Yee Mei Lee, BSN, MN, PhD, Belinda Tan, BHSN, GradDipNsg(Onc), Yen-Lin Chee, MBChB, FRCPath, PhD, Wei-Ying Jen, MA,FRCPath,MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-139138

Published: 2020

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis

Yin Jie Koh, Louis-Pierre Girard, MBChB, Hian Li Esther Hian Li Chan, MRCP, FRCPATH, Joanne Shu Xian Lee, MBBS, MRCP, Yen-Lin Chee, MBChB, FRCPath, PhD, Anand Jeyasekharan, Sanjay de Mel, MRCP(UK) FRCPath, Cinnie Yentia Soekojo, MD, Xin Liu, Liang Piu Koh, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Miny Samuel

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-138700

Published: 2020

Journal Articles

Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-138610

Published: 2020

Journal Articles

Reducing Time to Chemotherapy Administration in the Outpatient Setting of a Tertiary Cancer Centre Using a Design Thinking Approach

Wei-Ying Jen, BM BCh, FRCPath, Zhi Yao Chan, MSc (Clin Pharm), Mary Chong, BN, Mariana Ibrahim, BSN, Melinda Khoo, BSc (Hons), Judith Lee, BN, MSOL, Meng Tuck Lee, Dipl.-Ing. Univ., Yee Mei Lee, BSN, MN, PhD, Siew Woon Lim, MSc (Clin Pharm), Noel Ng, BBus(Mgt), Ednajoy Ngo, BHSN, MN, Belinda Tan, BHSN, GradDipNsg(Onc), Rui Xian Tay, MBA, Constance Teo, MSc (Clin Pharm), Yuet Peng Wong, MSc (Clin Pharm), Cheng Ean Chee, MBBS, ABIM (MDOnc), ABIM (Heme), FCAP, Yen-Lin Chee, MB ChB, FRCPath, PhD

Blood (2020) 136 (Supplement 1): 18–20.

https://doi.org/10.1182/blood-2020-138603

Published: 2020

Journal Articles

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Xiaojuan Chen, BsN, MsN, Foong-Gwan Lee, BsN, Shi Hui Clarice Choong, MBBS, MRCP, Xiao-Shi Saw, BSc(Pharm), Lon-Wann Sai, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Hian Li Esther Hian Li Chan, MBBS, MRCP, FRCPATH, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Yen Lin Chee, MBBS, FRCPATH, PhD, Yee Mei Lee, BsN, MsN, PhD

Blood (2019) 134 (Supplement_1): 2152.

https://doi.org/10.1182/blood-2019-129858

Published: 2019

Journal Articles

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients

Blood (2018) 132 (Supplement 1): 4111.

https://doi.org/10.1182/blood-2018-99-113952

Published: 2018

Journal Articles

Immunophenotypic and Genetic Characteristics of Diffuse Large B-Cell Lymphoma (DLBCL), and Prognostic Significance of Cell of Origin (COO) in a Southeast Asian Cohort

Vanessa CL Chong, Eng Soo Yap, MBBS, Liu Xin, Suk Teng Chin, Anand Jeyasekharan, Yen-Lin Chee, MBBS, MRCP, FRCPath, Hian Li Esther Chan, MBBS, Sanjay De Mel, Joanne Shu Xian Lee, MBBS, MRCP, Yee Mei Lee, Yi Ching Yuen, BPharm, Liang Piu Koh, MBBS, MRCP, Michelle Poon, MD

Blood (2018) 132 (Supplement 1): 4222.

https://doi.org/10.1182/blood-2018-99-119672

Published: 2018

Journal Articles

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Blood (2018) 132 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2018-99-118364

Published: 2018

Journal Articles

Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies

Blood (2017) 130 (Supplement 1): 1564.

https://doi.org/10.1182/blood.V130.Suppl_1.1564.1564

Published: 2017

NARROW

Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore

Evaluating the Comprehensive Geriatric Assessment Model As an Assessment Tool to Predict Chemotoxicity in Elderly Patients with Lymphoma

Outcomes of Elderly Patients with DLBCL and Utility of Geriatric Assessment Tools to Predict Chemotoxicity

Development of a Novel Artificial Intelligence Tool to Measure Psoas Volumes in Patients with Diffuse Large B Cell Lymphoma

A Non-Coding Variant in LOC105371512 Confers Susceptibility to Bleomycin-Induced Lung Injury

An Ex-Vivo Combination Drug Sensitivity Platform for Predicting Sensitivity to FLT3 Inhibitor-Based Combination in Acute Myeloid Leukemia

Cepp in Previously Untreated Patients with Mature T Cell Lymphomas

Evaluating Front Line Treatment Regimens for Waldenstrom Macroglobulinaemia: A Systematic Review and Meta-Analysis

Clinical Application of an Ex-Vivo Platform to Guide the Choice of Drug Combinations in Relapsed/Refractory Lymphoma; A Prospective Study

Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project

Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis

Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore

Reducing Time to Chemotherapy Administration in the Outpatient Setting of a Tertiary Cancer Centre Using a Design Thinking Approach

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients

Immunophenotypic and Genetic Characteristics of Diffuse Large B-Cell Lymphoma (DLBCL), and Prognostic Significance of Cell of Origin (COO) in a Southeast Asian Cohort

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only